Who owns Alveus Therapeutics?

Alveus Therapeutics is currently owned by Jeito Capital, through Jeito II, since 2026.

When did Jeito Capital acquire Alveus Therapeutics?

Jeito Capital acquired Alveus Therapeutics in 2026 (active for 0 years).

Home/Companies/Biotech/Alveus Therapeutics

Alveus Therapeutics

Biotech·

US·Active·0yr hold

Alveus Therapeutics is a healthcare company, headquartered in France.

Entry

2026

Hold

0yr

Status

Active

Est. EV

–

Most recent investor

Jeito Capital

3 ownership periods

Key facts

HQFrance

SectorHealthcare

Boston-based metabolic-disease biotech developing therapies for obesity and related disorders; Jeito Capital backed in USD 197M Series A…Read full notes

See the full ownership history.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Full fund context: vintage, strategy, region

Start free

Already a member? Sign in

More from Jeito II

Other portfolio companies in the same fund.

Augustine Therapeutics

More PE-backed in Biotech

Comparable biotech deals from other GPs.

AdBio PartnersBelgium

Last updated April 2026 · Sourced from public filings